key: cord-0822304-us969dk4
authors: Kamaleswaran, R.; Sadan, O.; Kandiah, P.; Li, Q.; Blum, J. M.; Coopersmith, C. M.; Buchman, T. G.
title: Changes in non-linear and time-domain heart rate variability indices between critically ill COVID-19 and all-cause sepsis patients -a retrospective study
date: 2020-06-07
journal: nan
DOI: 10.1101/2020.06.05.20123752
sha: da3a8f0a58183b68fddb52db5cf79f9d4db6db8f
doc_id: 822304
cord_uid: us969dk4

Objective: To measure heart rate variability metrics in critically ill COVID-19 patients with comparison to all-cause critically ill sepsis patients. Design and patients: Retrospective analysis of COVID-19 patients admitted to an ICU for at least 24h at any of Emory Healthcare ICUs between March and April 2020. The comparison group was a cohort of all-cause sepsis patients prior to COVID-19 pandemic. Interventions: none. Measurements: Continuous waveforms were captured from the patient monitor. The EKG was then analyzed for each patient over a 300 second (s) observational window, that was shifted by 30s in each iteration from admission till discharge. A total of 23 HRV metrics were extracted in each iteration. We use the Kruskal-Wallis and Steel-Dwass tests (p < 0.05) for statistical analysis and interpretations of HRV multiple measures. Results: A total of 141 critically-ill COVID-19 patients met inclusion criteria, who were compared to 208 patients with all-cause sepsis. Demographic parameters were similar apart from a high proportion of African-Americans in the COVID-19 cohort. Three non-linear markers, including SD1:SD2, sample entropy, approximate entropy and four linear features mode of Beat-to-Beat interval (NN), Acceleration Capacity (AC), Deceleration Capacity (DC), and pNN50, were statistical significance between more than one binary combinations of the sub-groups (comparing survivors and non-survivors in both the COVID-19 and sepsis cohorts). The three nonlinear features and AC, DC, and NN (mode) were statistically significant across all four combinations. Temporal analysis of the main markers showed low variability across the 5 days of analysis, compared with sepsis patients. Conclusions: Heart rate variability is broadly implicated across patients infected with SARS-CoV-2, and admitted to the ICU for critical illness. Comparing these metrics to patients with all-cause sepsis suggests a unique set of expressions that differentiate this viral phenotype. This finding could be investigated further as a potential biomarker to predict poor outcome in this patient population, and could also be a starting point to measure potential autonomic dysfunction in COVID-19.

The novel coronavirus (SARS-CoV-2) has led to a large cascade of transmissions resulting in high numbers of individuals hospitalized for the coronavirus disease 2019 , an impact still being accounted across the globe. A major target of the disease has been the respiratory components, resulting in acute respiratory insufficiency and failure. In patients who require mechanical ventilation, reported mortality rates exceed 50% (1, 2) . However, COVID-19 is not only a respiratory disease. Cardiac, renal, hemodynamic, hematological and neurological manifestations were noted in critically-ill COVID-19 patients (3) (4) (5) . The multi-system injury and high mortality rate requires means to identify patients at high risk. Heart rate variability (HRV) is a naturally occurring phenomena, which takes different patterns in critical illness (6) . HRV has long been associated to be a surrogate measure of cardiac autonomic tone (7) (8) (9) (10) . Analyzing complex dynamic features from the electrocardiogram (EKG), has been shown to indicate early cardiorespiratory complications (11, 12) , autonomic dysfunction (13) , sepsis (14) and death (15) . These HRV measures, drawn from both temporal and frequency domain, have also been used in predictive models for early and rapid identification of deterioration in the ICU (16) (17) (18) (19) (20) . However, the exploration of a comprehensive list of HRV metrics have not been investigated among COVID-19 patients. Therefore, in this All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 7, 2020. . https://doi.org/10.1101/2020.06.05.20123752 doi: medRxiv preprint

Temporal trajectories of each patient were generated to investigate differences in acuity and deterioration magnitude among COVID-19 survivors and non-survivors. Aggregate features of HRV were generated by uniformly sampling data across each 8-hour segment from admission until the fifth day. In-hospital mortality outcome was retrieved from the clinical record.

A total of 778 hospitalized patients were identified in a clinical chart review for positive SARS-CoV-2 tests by use of quantitative RT-PCR (qRT-PCR). From this cohort, 413 encounters were mapped to bedside monitors that were actively archiving data during the time of their hospitalization. We excluded 272 patients due to insufficient data or poor quality (>20% missing data) data from the first five days of ICU admission, leaving a total of 141 patients who were analyzed. We identified 557 encounters, pre-COVID-19, who met sepsis-3 criteria during their ICU stay and had high-frequency bedside monitoring captured. 208 of those encounters had sufficient data quality in the first five days of ICU stay, and eligible for the study. Table 1 presents a description of the clinical and demographic characteristics of the cohort. Notably, the proportion of African American patients in the COVID-19 cohort was over twice as the proportion in the sepsis cohort. Within both groups, the non-survivors were older on average, compared to the survivors.

A basic description of the different HRV indices of the COVID-19 and Sepsis group is detailed as a distribution histogram plot in Supplemental Figure 1 . While the total number of encounters in the sepsis group are greater, there was significantly more data available per encounter in the COVID-19 group. Prior to inclusion criteria being applied, there were approximately 680,799 seconds (~8 days) of data points on average per encounter in the COVID-19 group, while 206,288 seconds (2.4 days) in the sepsis group.

Descriptive statistics of the HRV measures are detailed in Table 2 . Notably, both Kruskal-Wallis and Steel-Dwass tests for multiple comparisons show statistically significant separations between the COVID-19 and all-cause sepsis groups. Specifically, on seven specific markers, which consists of three non-linear markers, including SD1:SD2, sample entropy (SampEn), approximate entropy (ApEn) and four linear features mode of Beat-to-Beat interval (NN), Acceleration Capacity (AC), Deceleration Capacity (DC), and pNN50, were statistical significance between more than one binary combinations of the sub-groups (comparing survivors and non-survivors in both the COVID-19 and sepsis cohorts). The three nonlinear features and AC, DC, and NN (mode) were statistically significant across all four combinations. A number of Beat-to-Beat interval metrics show significant QRS complex elongation between COVID-19 and sepsis, with the NN (mean) appearing on average, greater among both COVID-19 sub-groups than in sepsis survivors and non-survivors. Figure 1A illustrates a box-plot of the six highly differentiating measures, with their respective distributions rendered by a violin plot, illustrating kernel density in the background. Figure 1B illustrates correlation matrix of each HRV measure value, correlations were observed among metrics relating to vagal tone (RMSSD, pNN50, HF, SD1). Non-linear components consisting of SD1:SD2, SampEn, and ApEn was the most distinguishing factor between each sub-group, All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 7, 2020. . https://doi.org/10.1101/2020.06.05.20123752 doi: medRxiv preprint demonstrates a bimodal distribution within the COVID-19 survivors and non-survivors, which was not observed among the all-cause sepsis cohort.

AC and DC components were significantly different among the two broad groups, with COVID-19 groups having a lower DC but a greater AC median value compared to the sepsis groups. pNN50 in COVID 19 groups were on average lower in comparison to sepsis groups, where sepsis non-survivors had the largest pNN50 median. The correlation plot ( Figure 1B ) further shows high correlations among the beat-to-beat (NN*) derived features and HRV components attributed to parasympathetic activity. AC shows negative correlation with many of the time-frequency and nonlinear features, however no collinearity were found in ratios thought to represent sympathovagal balance (SD1:SD2, LF:HF, SampEn, ApEn). LF:HF ratio were found to have elevated median values between COVID-19 and all-cause sepsis, however is not distinguished when considering readings in non-survivors. Figure 1C illustrates a chord diagram of the interactions among the HRV measures with significant statistical significance across COVID-19 and all-cause sepsis cohorts using the Kruskal-Wallis and Steel-Dwass tests (P < 0.01). The three non-linear measures, along with AC DC, and NN (mode) had the greatest number of interactions (width of the link) among each of the four groups with a p value < 0.001. pNN50 had fewer strongly significant interactions, and could not differentiate COVID-19 non-survivors from survivors. SD1:SD2 had stronger statistical significance among Sepsis survivors and COVID-19 non-survivors.

Temporal trajectories of values were accumulated over each 8-hr segment of data and projected from admission until day 5. Figure 2 illustrates the normalized temporal trajectories for the six most statistically significant HRV measures between the cohorts, the 95% confidence interval (CI) is marked by the shaded region around each line. The mode of NN, pNN50, ApEn, and SampEn starts lower in the COVID-19 cohort and after 5 days remains lower than the sepsis cohort. While DC and SD1:SD2 begin higher in the COVID-19 cohort and end lower during the same timeframe. AC, DC, pNN50, NN (mode), the 95% CI is much tightly bound in COVID-19 patients. While among the non-linear metrics the 95% CI bound is much broader. Within all seven HRV measures, the sepsis cohort demonstrates dynamic fluctuations over their ICU stay that are not observed within the COVID-19 patients.

By comparing retrospective cohorts of COVID-19 and non-COVID-19 all-cause sepsis patients, this study demonstrates a distinctively expressed subsets of nonlinear and time domain HRV measures. The results show marked separation between sepsis and COVID-19 patients, and also separates between survivors and non-survivors.

When comparing the cohorts from a demographic stand point, there were significantly more African Americans in the COVID-19 dataset, which is consistent with recent reports (24) . There was no meaningful difference between mortality among ethnicities. No distinctive differences by sex was observed in outcomes, with about an equal number of male non-survivors (52%).

Out of the battery of HRV indices analyzed, only some were able to separate the groups (COVID-19 and sepsis) and subgroups (survivors and non-survivors) in a statistically significant All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 7, 2020. . https://doi.org/10.1101/2020.06.05.20123752 doi: medRxiv preprint manner. The most statistically significant measure of HRV across multiple-groups was ApEn, SampEn and SD1:SD2. ApEn derived from methods of information theory, is a measure of the degree of nonstationarity, and higher values indicate poor irregularity and thus suggested a poor parasympathetic tone. SampEn, is a similar measure of signal complexity as ApEn, however a more robust one, when considering shorter observational time. Both SampEn and ApEn were lower in the COVID-19 cohort than in all-cause sepsis, indicating a reduced dynamic in heart rate modulation.

Of the significant time-domain HRV indices we measured (Table 3) , pNN50, AC, DC, and NN (mode) strongly distinguished COVID-19 patients from all-cause sepsis. Cardiovascular complications within COVID-19 has been documented in many recent works (25) (26) (27) . In our results we see on average a greater NN value (lower heart rates) within COVID-19 patients when compared to all-cause sepsis. Apart from NN (mode), most beat-to-beat metrics show a higher baseline distance among COVID-19 patients. IQR of NN shows that COVID-19 profiles among survivors and non-survivors are closer to all-cause sepsis non-survivors, indicating a potential increase in risk for mortality. pNN50 has long been a predictor of poor cardiac physiology (28) . In our analysis, we see that after day 2 (7 th block, pNN50, Figure 2 ), the mean pNN50 distinguishes from earlier periods and has a distinct difference progressively during the ICU stay. COVID-19 seems to significantly decreased DC, while AC was higher (Figure 1 ). Increased AC and decreased DC has specifically been shown to be predictive of mortality in myocardial infraction (29) and heart failure (30), and both AC and DC components were implicated in inflammatory mediation (31) and indicate significant vagal activation (32) . In particular, decreased DC has been shown to be linked with impaired PNS activity (33) . Interestingly, evaluating temporal trajectories also emphasize distinct characteristics between the groups, while the trajectory of values among the COVID-19 group did not change significant over time, in contrast a greater degree of temporal dynamics was observed in the sepsis cohort ( Figure 2 ).

The ratio of SD1:SD2 derived from the Poincaré Plot, a visual geometric measure of selfsimilarity in periodic functions. SD1 has been correlated with the baroreflex sensitivity and measures short-term changes modulated by respiratory sinus arrhythmia (RSA) associated to parasympathetic activity (34) . The SD1:SD2 ratio is a measure of autonomic balance, whereby decreased SD1:SD2 ratio indicates an elevated sympathetic tone and suppressed parasympathetic activity (35) . It was interesting to note that in our dataset the COVID-19 group had a marginally higher SD1:SD2 ratio than all-cause sepsis, in contrast to findings from DC, pNN50, SampEn and ApEn which indicate a lower parasympathetic tone. An elevated SD1:SD2, may indicate a broad and complex dynamics between the sympathetic and parasympathetic arms, and/or medication influence being reflected in COVID-19.

There are several pathophysiological explanations for the differences shown between COVID-19 and sepsis patients. One option relates to a direct cardiac injury. Indeed, cardiac manifestations in COVID-19 patients are common (5) . A direct injury could theoretically damage the cardiac pacer or the conduction system, resulting in changes of HRV. A second option to be considered is an injury to the autonomic system. Many of the parameters found to differentiate the groups in this cohort, were previously correlated with changes in the All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 7, 2020. . https://doi.org/10.1101/2020.06.05.20123752 doi: medRxiv preprint sympathovagal tone (12, 13) . The level of neuro-tropism of SARS-CoV-2 remains unclear, and specifically whether or not it could invade parasympathetic fibers via the gastrointestinal tract or the lungs.

A third option could be related to the binding of SARS-CoV-2 to ACE2, resulting in the loss of the protective pathway against a dysregulated autonomic system (36) . The loss of ACE2 function has been associated to binding of the SARS-CoV-2 virus driven by endocytosis and initiation of the proteolytic cleavage and processing. ACE2 regulates the RAS system by converting Ang I and Ang II into Ang 1-9 and Ang 1-7, respectively (37, 38) . Loss of function of the ACE2 receptor, and thus an unregulated Ang II has been associated with hypertension and cardiovascular autonomic dysfunction (39) . In a cohort of 12 COVID-19 patients, circulating Angiotensin II was found to be significantly elevated when compared to controls, and showed linear relationship with viral load (40) . Ang II exerts several actions on the sympathetic arm of the autonomic nervous system, facilitating increased sympathetic outflow and neurotransmission. It also acts on the baroreflex mechanism to modulate blood pressure (41, 42) , and therefore by surrogate influence the cardiac non-stationarity. Finally, the targeting of the respiratory system by the SARS-CoV-2 virus impacts breathing rate, and thus the respiratory sinus arrhythmia (RSA), which in turn modulates high-frequency activities of the cardiac system.

The combination of the seven non-linear and temporal HRV measures indicates potential sympathovagal imbalance within this pilot study, with various degrees of interaction between the sympathetic and parasympathetic arms. Among COVID-19 patients, there were more pathological regularity observed both overall and temporally. This indicates potential suppressed parasympathetic activity that may be driven by interference with the RAS system. Parallel influences from respiratory components, affecting the RSA further contribute to a dysfunctional autonomic regulation of the cardiac system. These cues, as shown within this analysis, can be distinctive between the cohorts, including between survivors and non-survivors, and therefore potentially predictive of mortality.

Limitations: There are a number of limitations of this study, including the fact that only 141 COVID-19 patients were eligible for inclusion. Furthermore, the analysis was performed on a cohort from multiple hospitals and units, yet still from a single health system in a single metropolitan. COVID-19 related mortality in our health system was lower than prior reports which could affect generalizability. This study was an observational cohort study performed retrospectively, and therefore causality analysis is limited. Specifically, this study did not examine the correlation between the HRV metrics and medications used to treat the patients. Additional work needs to be done to evaluate the performance of these measures prospectively. Developing methods to automatically capture this data and generate point-of-care biomarkers is an active area of ongoing work (43, 44) .

Heart rate variability is broadly implicated across patients infected with SARS-CoV-2, and admitted to the ICU for critical illness. These biomarkers may suggest a degree of autonomic dysfunction that can be longitudinally expressed. Key subsets of measures were identified across time, frequency and nonlinear domains. The results highlight potential biomarkers that could separate COVID-19 patients from all-cause sepsis patients. More importantly, these results prove All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 7, 2020. . https://doi.org/10.1101/2020.06.05.20123752 doi: medRxiv preprint preliminary data to allow early separation of survivors and non-survivors. Temporal trajectories of these markers further suggest significant decoupling as the disease progresses, with salient decoupling noticeable as early as at ICU admission. While the results of this study are early, we establish the premise that these higher-dimensional features of heart rate can be associated with poor outcomes among COVID-19 patients.

This work was partially funded by the Surgical Critical Care Initiative (SC2i).

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 7, 2020. All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 7, 2020. 

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 7, 2020. 

Covid-19 in Critically Ill Patients in the Seattle Region -Case Series

Characteristics and Outcomes of 21 Critically Ill Patients with COVID-19 in Washington State

COVID-19 and its implications for thrombosis and anticoagulation

Neurological manifestations and neuro-invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2

SARS-CoV-2 and viral sepsis: observations and hypotheses

Heart rate variability in critical illness and critical care

Heart rate variability: A measure of cardiac autonomic tone

Heart Rate Variability

Heart rate variability -A historical perspective

Autonomic dysfunction in the ICU patient

Cardiorespiratory instability before and after implementing an integrated monitoring system

Defining the incidence of cardiorespiratory instability in patients in step-down units using an electronic integrated monitoring system

Heart rate variability: A diagnostic and prognostic tool in anesthesia and intensive care

Heart Rate Characteristics : Novel Physiomarkers to Predict Neonatal Infection and Death

The pulse of inflammation: Heart rate variability, the cholinergic anti-inflammatory pathway and implications for therapy

Applying Artificial Intelligence to Identify Physiomarkers Predicting Severe Sepsis in the PICU

A minimal set of physiomarkers in continuous high frequency data streams predict adult sepsis onset earlier

Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease

Continuous multi-parameter heart rate variability analysis heralds onset of sepsis in adults

Early sepsis detection in critical care patients using multiscale blood pressure and heart rate dynamics

The third international consensus definitions for sepsis and septic shock (sepsis-3)

An open source benchmarked toolbox for cardiovascular waveform and interval analysis

Scikit-learn: Machine Learning in Python

COVID-19 and African Americans

COVID-19, Arrhythmic Risk and Inflammation: Mind the Gap! Circulation

Clinical Characteristics of Coronavirus Disease 2019 in China

Critical care crisis and some recommendations during the COVID-19 epidemic in China

The pNNx files: re-examining a widely used heart rate variability measure

Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study

Deceleration and acceleration capacities of heart rate associated with heart failure with high discriminating performance

Are the Associations of Cardiac Acceleration and Deceleration Capacities With Fine Metal Particulate in Welders Mediated by Inflammation?

Do the deceleration/acceleration capacities of heart rate reflect cardiac sympathetic or vagal activity? A model study

Deceleration capacity alterations before Non-Sustained Ventricular Tachycardia episodes in post myocardial infarction patients

The influence of changing respiratory rate on HRV is portrayed by descriptors of Poincaré plot analysis

Poincaré plot indexes of heart rate variability detect dynamic autonomic modulation during general anesthesia induction

Angiotensin Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System

Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure

The ACE2/Angiotensin-(1-7)/Mas axis of the reninangiotensin system: Focus on Angiotensin

Chronic activation of endogenous angiotensin-converting enzyme 2 protects diabetic rats from cardiovascular autonomic dysfunction

Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury

Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure

Angiotensin II in central nervous system physiology

Service oriented architecture for the integration of clinical and physiological data for real-time event stream processing

PhysOnline: An Open Source Machine Learning Pipeline for Real-Time Analysis of Streaming Physiological Waveform

No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version

All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted June 7, 2020. . https://doi.org/10.1101/2020.06.05.20123752 doi: medRxiv preprint All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted June 7, 2020. . https://doi.org/10.1101/2020.06.05.20123752 doi: medRxiv preprint All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted June 7, 2020. . https://doi.org/10.1101/2020.06.05.20123752 doi: medRxiv preprint All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted June 7, 2020. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted June 7, 2020. . https://doi.org/10.1101/2020.06.05.20123752 doi: medRxiv preprint